undamentalytics Newsletter

Zevia PBC (ZVIA) stock

Add holding +

NYSE: ZVIA NYSE Beverages Next results ~November 4, 2026

C Fundamentals grade

Zevia PBC is a US-listed company in the beverages industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$3.7

Valuation models combined (3)

Base case. Range ~$3.4–$4.2. Weighted average of 3 models (growth cash-flow model, forward price-to-sales vs peers, revenue-to-maturity model), the growth cash-flow model counting double.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 4 selling0 purchases and 8 sales by directors and officers, last 12 monthsInsider trades
  • Funds61 adding, 68 cuttingOf 23 active managers that changed their stake, 12 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Zevia PBC files

Where Zevia PBC stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $170m, up 7.2% on a year earlier, slower than the 9.8% growth a quarter earlier. Free-cash-flow margin rose to 1.7% from -1.6% a year earlier. Operating margin widened to -5.7% from -10.5%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 2 financial-health checks. Our revenue-to-maturity cash-flow model value is $4.78 a share, against a share price of $1.25.

Source: 10-Q filed August 5, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Zevia PBC's trailing-twelve-month revenue grew 7.2% year on year, with a free-cash-flow margin of 1.7%.

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 18% in the quarter to 2026-06-30, the 4th beat in the last four quarters.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Strengths

  • Margins widening. Operating margin is up 4.9 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.0bn.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Results due soon. Results are expected around 4 November; the share price can move sharply on the day.
  • Loss-making. Operating margin is -5.7%: costs exceed revenue.
  • Volatile shares. Over the past year the shares showed annualised volatility of 68% and a beta of 0.7 against the S&P 500.
  • Insiders selling. 4 insiders sold $12M of stock over the past 365 days and none bought (0% under pre-set trading plans).
  • Growth easing. The growth rate is 2.5 points lower than a quarter earlier.
  • Below peers: stock pay as % of revenue. Stock pay as % of revenue of 3.0% ranks 18 of 23 beverages companies we cover (median 1.2%).

Latest results: FY2026 Q2

Filed August 5, 2026
Earnings per share
-$0.02 against an average estimate of -$0.03: beat by 18.1%
Revenue
$45m, up 1.1% on a year earlier
Share reaction
-15.0% in the first session after the results on August 5, 2026, against -0.4% for the S&P 500
Next report
November 4, 2026; average EPS estimate -$0.05

Zevia PBC's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-5.9%
  • 1 week-11.8%
  • 1 month-7.4%
  • This year-51.7%
  • 1 year-52.5%
  • 5 years-90.9%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$170M
Operating margin
-5.7%
Net margin
-5.3%
EPS (TTM, diluted)
$-0.14

Growth

Revenue growth
+7.2%
Change in growth rate
−2.5 pts
Share count change
−0.7%

Cash

Free cash flow (TTM)
$2.9M
FCF margin
1.7%
Stock pay % of revenue
3.0%

Earnings

Last results
August 5, 2026
Next results (est.)
November 4, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Zevia PBC as an operating company, with every model that fits that kind of business. Cost of equity 8.9%: the 10-year Treasury yield (4.9%) plus a beta of 0.88 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$3.4 ~$2.4–$4.2 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$3.6 ~$2.6–$6.1 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$4.2 ~$3.5–$5.2 Included
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$3.7 ~$3.4–$4.2 3 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Zevia PBC with Beverages in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

Zevia PBC: market value and multiples by fiscal year
At fiscal year end 20212022202320242025Now
Share price$7.05$4.09$2.01$4.19$2.32$1.12
Market value$243m$178m$102m$246m$153m$73m
+ Net debt (− = net cash)−$43m−$47m−$32m−$31m−$25m−$28m
Enterprise value$200m$130m$70m$215m$128m$45m
Multiples
Price / sales 1.8x1.1x0.6x1.6x0.9x0.4x
Price / earnings ——————
Price / free cash flow —————25.2x
EV / EBITDA ——————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

43 /100

Weak moat

How hard Zevia PBC's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -2.8% of total assets over 5 years.

  • Pricing power 16 / 20

    Gross margin has been a median 45.8%, moving by 2.2 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -12.6%; its worst year was -44.2%.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, after the close. Analysts expect revenue of $45m and EPS of −$0.05 (range −$0.06 to −$0.04) for the quarter.

Analysts' consensus

Zevia PBC: consensus estimates
Fiscal yearEPSGrowthRevenueGrowth
Current −$0.13 −9% $174m +8%
Next −$0.07 +41% $185m +6%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +0.7% on 90 days ago. In the last 30 days, 1 analyst raised Zevia PBC's forecast and 0 cut it.

Consensus EPS forecast Zevia PBC, last 90 days
−$0.15 −$0.10 −$0.05 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.13 Current fiscal year, 60 days ago: −$0.13 Current fiscal year, 30 days ago: −$0.13 Current fiscal year, 7 days ago: −$0.13 Current fiscal year, Now: −$0.13 −$0.13 Next fiscal year, 90 days ago: −$0.11 Next fiscal year, 60 days ago: −$0.07 Next fiscal year, 30 days ago: −$0.07 Next fiscal year, 7 days ago: −$0.07 Next fiscal year, Now: −$0.07 −$0.07

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.13−$0.11
60 days ago −$0.13−$0.07
30 days ago −$0.13−$0.07
7 days ago −$0.13−$0.07
Now −$0.13−$0.07

Earnings against estimates

Zevia PBC: reported EPS against the consensus estimate
Quarter toEstimateActualSurprise
Jun 2026 −$0.03 −$0.02 +18.1%
Mar 2026 −$0.03 −$0.00 +94.9%
Dec 2025 −$0.03 −$0.02 +20.0%
Sept 2025 −$0.05 −$0.04 +20.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

6 analysts, Oct 2026
Buy583%
Hold117%
Sell00%

Monthly trend

  1. Oct 2026516
  2. Sep 2026516

Counts of recommendations published by analysts covering Zevia PBC, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
1.7%
of tradable shares
Days to cover
2.68
at average volume
Short interest, 1 month
−21%
to October 15, 2026
Held by institutions
59%
of shares
Held by insiders
6.5%
of shares
Employees
91
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

What moved the share price

Last 12 months −52.5%

$2.36 on October 31, 2025 to $1.12

Zevia PBC: share-price change split into its parts
PartThenNowEffect
Revenue (last 12 months) $158m $170m +7.2%
P/S multiple 1.0x 0.4x −56.0%
Share count 66m 65m +0.7%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −45.9%

$2.07 on November 3, 2023 to $1.12

Zevia PBC: share-price change split into its parts
PartThenNowEffect
Revenue (last 12 months) $165m $170m +2.8%
P/S multiple 0.7x 0.4x −36.2%
Share count 54m 65m −17.5%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Zevia PBC: yearly return, monthly win rate and worst fall against the S&P 500
Calendar year 20222023202420252026 to date
Return
ZVIA−42%−51%+109%−45%−52%
Industry peers (median)+1%−4%−13%−36%−2%
S&P 500−18%+26%+25%+18%+11%
Months that ended higher
ZVIA42%42%50%33%46%
S&P 50042%67%75%75%46%
Largest fall from a high during the year
ZVIA−81%−65%−69%−58%−52%
S&P 500−25%−10%−8%−19%−9%

Worst fall since July 22, 2021: 96% from September 3, 2021 to July 8, 2024. Getting back needed a 2650% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$1.12 – $2.71
From 52-week high
−58.7%
vs 50-day average
−12.6%
vs 200-day average
−21.3%
Volatility (1 year)
68%
Beta vs S&P 500
0.74

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±14.1%
After a week
6 up, 6 down
typical move ±18.8%
After a month
5 up, 7 down
typical move ±33.2%
Zevia PBC: share-price change after each results release
Results releasedNext dayS&P 500 next day5 days21 days
August 5, 2026 −15.0% −0.4% −22.0% −20.8%
May 6, 2026 +4.0% +1.1% −3.2% +12.8%
February 25, 2026 −10.0% +0.3% −4.7% −22.0%
November 5, 2025 +13.9% −0.7% +17.3% +11.7%
August 6, 2025 +0.9% +0.7% −8.8% −21.3%
May 7, 2025 +52.5% +1.1% +43.1% +29.2%
February 26, 2025 −31.6% −1.5% −26.4% −34.7%
January 13, 2025 −7.5% +0.3% +7.2% −25.1%
November 6, 2024 +10.1% +3.3% +68.8% +161.5%
August 7, 2024 −6.9% +1.6% +13.3% +13.3%
May 8, 2024 −16.3% +0.6% +1.9% −10.7%
February 27, 2024 0.0% +0.1% −9.3% −34.8%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Zevia PBC in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Zevia PBC
$150M $155M $160M $165M $170M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $164M Revenue (TTM), FY23 Q4: $166.4M Revenue (TTM), FY24 Q1: $161.9M Revenue (TTM), FY24 Q2: $160.1M Revenue (TTM), FY24 Q3: $153.4M Revenue (TTM), FY24 Q4: $155M Revenue (TTM), FY25 Q1: $154.3M Revenue (TTM), FY25 Q2: $158.4M Revenue (TTM), FY25 Q3: $162.8M Revenue (TTM), FY25 Q4: $161.3M Revenue (TTM), FY26 Q1: $169.3M Revenue (TTM), FY26 Q2: $169.8M $169.8M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $164M
FY23 Q4 $166.4M
FY24 Q1 $161.9M
FY24 Q2 $160.1M
FY24 Q3 $153.4M
FY24 Q4 $155M
FY25 Q1 $154.3M
FY25 Q2 $158.4M
FY25 Q3 $162.8M
FY25 Q4 $161.3M
FY26 Q1 $169.3M
FY26 Q2 $169.8M
Revenue growth, TTM YoY Zevia PBC
-10% -5% 0% 5% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 1.2% Revenue growth, TTM YoY, FY23 Q4: 2.0% Revenue growth, TTM YoY, FY24 Q1: -3.9% Revenue growth, TTM YoY, FY24 Q2: -3.1% Revenue growth, TTM YoY, FY24 Q3: -6.5% Revenue growth, TTM YoY, FY24 Q4: -6.8% Revenue growth, TTM YoY, FY25 Q1: -4.7% Revenue growth, TTM YoY, FY25 Q2: -1.1% Revenue growth, TTM YoY, FY25 Q3: 6.2% Revenue growth, TTM YoY, FY25 Q4: 4.0% Revenue growth, TTM YoY, FY26 Q1: 9.8% Revenue growth, TTM YoY, FY26 Q2: 7.2% 7.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 1.2%
FY23 Q4 2.0%
FY24 Q1 -3.9%
FY24 Q2 -3.1%
FY24 Q3 -6.5%
FY24 Q4 -6.8%
FY25 Q1 -4.7%
FY25 Q2 -1.1%
FY25 Q3 6.2%
FY25 Q4 4.0%
FY26 Q1 9.8%
FY26 Q2 7.2%
Operating margin (TTM) Zevia PBC
-30% -20% -10% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -16.1% Operating margin (TTM), FY23 Q4: -17.4% Operating margin (TTM), FY24 Q1: -20.4% Operating margin (TTM), FY24 Q2: -21.7% Operating margin (TTM), FY24 Q3: -17.1% Operating margin (TTM), FY24 Q4: -15.3% Operating margin (TTM), FY25 Q1: -14.8% Operating margin (TTM), FY25 Q2: -10.5% Operating margin (TTM), FY25 Q3: -10.2% Operating margin (TTM), FY25 Q4: -7.3% Operating margin (TTM), FY26 Q1: -4.6% Operating margin (TTM), FY26 Q2: -5.7% -5.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -16.1%
FY23 Q4 -17.4%
FY24 Q1 -20.4%
FY24 Q2 -21.7%
FY24 Q3 -17.1%
FY24 Q4 -15.3%
FY25 Q1 -14.8%
FY25 Q2 -10.5%
FY25 Q3 -10.2%
FY25 Q4 -7.3%
FY26 Q1 -4.6%
FY26 Q2 -5.7%
FCF margin (TTM) Zevia PBC
-30% -20% -10% 0% 10% FY21 Q3 FY22 Q2 FY23 Q1 FY26 Q2 FCF margin (TTM), FY21 Q3: -12.6% FCF margin (TTM), FY21 Q4: -15.2% FCF margin (TTM), FY22 Q1: -20.8% FCF margin (TTM), FY22 Q2: -25.5% FCF margin (TTM), FY22 Q3: -16.7% FCF margin (TTM), FY22 Q4: -14.3% FCF margin (TTM), FY23 Q1: -1.7% FCF margin (TTM), FY23 Q2: -1.6% FCF margin (TTM), FY25 Q3: -4.0% FCF margin (TTM), FY25 Q4: -3.1% FCF margin (TTM), FY26 Q1: -0.4% FCF margin (TTM), FY26 Q2: 1.7% 1.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY21 Q3 -12.6%
FY21 Q4 -15.2%
FY22 Q1 -20.8%
FY22 Q2 -25.5%
FY22 Q3 -16.7%
FY22 Q4 -14.3%
FY23 Q1 -1.7%
FY23 Q2 -1.6%
FY25 Q3 -4.0%
FY25 Q4 -3.1%
FY26 Q1 -0.4%
FY26 Q2 1.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Zevia PBC: annual financial statements
Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 110 138 163 166 155 161 170
Gross profit 50 64 70 75 72 77 81
EBITDA −5 −86 −47 −27 −22 −11 −9
Operating income −5 −87 −48 −29 −24 −12 −10
Net income −6 −88 −48 −21 −20 −10 −9
Diluted EPS — −$1.33 −$0.81 −$0.41 −$0.34 −$0.15 −$0.14
Growth (year on year)
Revenue — +25.6% +18.1% +2.0% −6.8% +4.0% +7.2%
Margins
Gross margin 45.0% 46.3% 42.9% 44.9% 46.4% 48.0% 47.7%
EBITDA margin −4.1% −62.6% −28.5% −16.4% −14.4% −6.8% −5.3%
Operating margin −5.0% −63.3% −29.3% −17.4% −15.3% −7.3% −5.7%
Net margin −5.5% −63.4% −29.2% −12.9% −12.9% −6.2% −5.3%
Free-cash-flow margin −3.7% −15.2% −14.3% — −0.8% −3.1% 1.7%
Cash flow
Cash from operations −3 −18 −21 −16 −1 −5 4
Capital spending 1 3 3 — 0 0 1
Free cash flow −4 −21 −23 — −1 −5 3
Stock-based pay 8 78 27 8 5 4 5
Free cash flow after stock pay −12 −99 −50 — −6 −9 −2
Balance sheet
Cash 15 43 47 32 31 25 28
Total debt 0 0 0 0 0 0 0
Net debt (negative = net cash) −15 −43 −47 −32 −31 −25 −28
Diluted shares — 34m 43m 51m 59m 66m 65m
Returned to shareholders
Buybacks — 0 0 — — — —
Total returned — 0 0 — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $64m
Short-term assets $59mLonger-term assets $6m
What it owes, and who funded it · $75m
Short-term liabilities $31mLonger-term liabilities $0mShareholders' equity $44m
  • Short-term assets cover short-term liabilities $59m of assets due within a year against $31m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $59m short-term assets against $0 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Zevia PBC's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
−0.7%
year over year
Days sales outstanding
22 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in beverages
Growth, margins and cash generation against peers
Last 12 months unless stated ZVIA BRCC MGPI SNDL WVVI COCO Median
Revenue, last 12 months $170m $437m $487m $678m $38m $768m $723m
Revenue growth, last 12 months 7.2% 11.7% −15.9% 0.8% −1.6% 26.0% 6.6%
Revenue growth, 3-year average 0.9% 5.7% −15.7% — −0.2% 17.0% 4.3%
Revenue growth, latest quarter 1.1% 7.3% −9.9% — −1.6% 33.7% 6.4%
Gross margin 47.7% 34.1% 34.7% 27.3% 59.1% 41.0% 42.6%
Operating margin −5.7% −2.8% −57.2% −0.7% −7.9% 19.9% −0.9%
Operating margin, 3-year average −12.6% −3.1% −11.8% — −3.0% 15.9% 11.9%
Net margin −5.3% −1.5% −51.4% −1.7% −5.9% 15.7% −1.6%
Cash from operations / revenue 2.1% 0.4% 4.2% 7.5% 2.6% 19.3% 9.9%
Free-cash-flow margin 1.7% −0.1% 0.1% 6.1% 1.7% 18.8% 9.0%
Free-cash-flow margin, 3-year average −8.5% 0.4% 5.5% — −7.6% 14.0% 8.8%
Stock pay / revenue 3.0% 2.5% 1.1% 1.5% 0.4% 1.8% 1.2%
Change in share count −0.7% 26.2% −0.2% −2.3% 0.0% 1.2% 0.0%

Median of all 26 companies we cover in beverages. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

26 beverages companies
Measures ranked against peers
Measure Company Peer median Rank
Revenue growth Growth 7.2% 6.9% 11 of 26
Change in growth rate Growth -2.5pp +0.6pp 20 of 26
Gross margin Profitability 47.7% 44.2% 12 of 26
Operating margin Profitability -5.7% -0.7% 17 of 26
Net margin Profitability -5.3% -1.5% 17 of 26
Free-cash-flow margin Cash generation 1.7% 9.6% 15 of 24
Stock pay as % of revenue Cash generation 3.0% 1.2% 18 of 23
Change in share count Balance sheet -0.7% 0.0% 5 of 19
Days sales outstanding Balance sheet 22 days 33 days 6 of 21

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $145M 89.9% ▲ 3.7%
Canada $16.3M 10.1% ▲ 6.7%

From Zevia PBC's 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Reported value
$67.8M
Institutions reporting
102
Shares held vs prior quarter
▼ 7.7%
Positions opened / closed
26 / 40

Top buyers and sellers, Q2 2026: 61 institutions bought and 68 sold ; the biggest buyer was Mackenzie Financial Corp (+2.5M shares) and the biggest seller Blackrock, Inc (−2.3M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Caisse De Depot Et Placement Du Quebec $18.6M 11.4M 27.4% ▼ 15.9%
Topline Capital Management, LLC $11.7M 7.2M 17.3% ▲ 6.4%
Kanen Wealth Management LLC $4.6M 2.7M 6.8% ▲ 115.5%
Mackenzie Financial Corp $4.4M 2.7M 6.4% ▲ 2051.2%
Vanguard Capital Management LLC $3.5M 2.1M 5.1% ▲ 25.9%
Jefferies Financial Group Inc. $3.4M 2.1M 5.1% ▲ 0.2%
Stoic Point Capital Management LLC $1.8M 1.1M 2.7% ▲ 53.1%
Jane Street Group, LLC $1.6M 969K 2.3% New
AQR Capital Management LLC $1.5M 920K 2.2% ▲ 73.7%
Blackrock, Inc. $1.3M 804K 1.9% ▼ 74.2%
Squarepoint Ops LLC $1.3M 770K 1.9% ▲ 41.1%
Renaissance Technologies LLC $1.2M 766K 1.8% ▼ 5.7%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Zevia PBC's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Recent insider open-market transactions
Insider Date Trade Shares Price Value
Cdp Investissements Inc. 10% owner May 27, 2026 Sell 2,150,000 $1.90 $4.1M
Taylor Amy President & CEO March 30, 2026 Sell 10,776 $1.16 $12,500
Taylor Amy President & CEO March 27, 2026 Sell 66,501 $1.14 $75,811
Taylor Amy President & CEO March 26, 2026 Sell 66,731 $1.17 $78,075
Satya Girish Chief Financial Officer March 25, 2026 Sell 41,662 $1.18 $49,161
Spence Padraic L. Director March 3, 2026 Sell 40,000 $1.44 $57,600
Cdp Investissements Inc. 10% owner January 27, 2026 Sell 3,500,000 $2.00 $7M
Spence Padraic L. Director November 10, 2025 Sell 200,000 $2.64 $528,000

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 4, 2026 estimated from the company's past filing pattern, not announced

  • August 5, 2026
  • May 6, 2026
  • February 25, 2026
  • November 5, 2025
  • August 6, 2025
  • May 7, 2025

Recent SEC filings

Data status

When each part of this page on Zevia PBC was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Zevia PBC in brief

What does Zevia PBC do?
Zevia PBC is a US-listed company in the beverages industry. Its financial year ends in December.
What is Zevia PBC's stock ticker?
Zevia PBC trades under the ticker ZVIA on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Zevia PBC's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Zevia PBC reported revenue of $170M, 7.2% higher than a year earlier, according to its SEC filings.
What is Zevia PBC's free cash flow?
Zevia PBC's free-cash-flow margin is 1.7% of revenue over the trailing twelve months, ranking 15 of the 24 beverages companies we cover.
Who are Zevia PBC's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Caisse De Depot Et Placement Du Quebec, Topline Capital Management, LLC and Kanen Wealth Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Zevia PBC's market cap?
On November 2, 2026, Zevia PBC's market capitalisation was about $73.2M and net debt of -$28.5M. Market figures come from third-party market data and may be delayed.
Who are Zevia PBC's competitors?
In our Beverages peer group, the companies closest to Zevia PBC are BRC Inc., MGP Ingredients Inc, Sndl Inc., Willamette Valley Vineyards Inc and Vita Coco Company, Inc. The side-by-side comparison below sets their revenue, margins and growth against Zevia PBC's.
Are insiders buying or selling Zevia PBC stock?
Over the last 12 months, Zevia PBC's directors and officers reported 0 open-market purchases and 8 sales on Form 4. The insider trading page charts every trade.
When is Zevia PBC's next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Zevia PBC announces its own schedule.